Oncology & Cancer

Overcoming resistance to a standard chemotherapy drug

Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

Diseases, Conditions, Syndromes

Scientists develop novel technique for kidney research

One in four patients treated with the widely used anti-cancer drug cisplatin develop chronic kidney disease. To better understand how the treatment leads to kidney damage, and possibly prevent it, a team of researchers at ...

Oncology & Cancer

New ruthenium-based drugs show promise for killing cancer cells

A new study by University of Kentucky researchers shows how light and strained ruthenium-based drugs may be more effective at fighting cancer cells and less toxic to healthy cells than a similar and widely used drug.

Oncology & Cancer

New research could lead to more effective chemotherapy

An international team of researchers led by Hassan Beyzavi of the University of Arkansas, is studying the use of platinum and gold to enable more effective forms of chemotherapy.

page 2 from 4